New Delhi, Delhi
GST No. 07AAKFN5053A1ZK
Call 08048982480 88% Response Rate
Send Enquiry
Product Brochure
| Strength | 250 mg |
| Brand | Temoside |
| Capsules per Pack | 5 Capsules |
| Pack Type | Bottle |
| Form | Capsule |
| Prescription Type | Prescription |
| Salt Composition | Temozolomide Capsules |
Temoside 250mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antineoplastic agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temoside 250mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temoside 250mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to be associated with Temoside 250mg Capsule are nausea, vomiting, dizziness, diarrhoea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temoside 250mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anaemia, low platelet count, low levels of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 100 mg |
| Brand | Temoside |
| Capsules per Pack | 5 Capsules |
| Pack Type | Bottle |
| Form | Capsule |
| Prescription Type | Prescription |
| Salt Composition | Temozolomide Capsules |
| Marketer | CIPLA LTD |
Temoside 100mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temoside 100mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temoside 100mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Temoside 100mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temoside 100mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 20 mg |
| Brand | Glioz |
| Capsules per Pack | 5 Capsules |
| Manufacturer | DR REDDY'S LABORATORIES LTD |
| Usage/Application | Commercial |
| Salt Composition | Temozolomide Capsules |
| Brand Name | Glioz 20mg |
| Pack Size | 5 CAPSULE(s) IN A BOX |
Glioz 20mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Glioz 20mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Glioz 20mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Glioz 20mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Glioz 20mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 250 mg |
| Brand | Temotero |
| Capsules per Pack | 5 Capsules |
| Manufacturer | Hetero Healthcare Ltd |
| Usage/Application | Hospital |
| Salt Composition | Temozolomide 250mg Capsules |
| Country of Origin | India |
| Pack Size | 5 Capsule(s) In A Bottle |
Temotero 250mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temotero 250mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temotero 250mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Temotero 250mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temotero 250mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 100 mg |
| Brand | Temcad |
| Capsules per Pack | 5 Capsules |
| Manufacturer | CADILA PHARMACEUTICALS LTD |
| Usage/Application | Hospital |
| Brand name | Temcad 100mg |
| Salt Composition | Temozolomide Capsules |
| Pack Size | 5 Capsules |
Temcad 100mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temcad 100mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temcad 100mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Temcad 100mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temcad 100mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 250 mg |
| Brand | Glioz |
| Capsules per Pack | 5 Capsules |
| Packaging Size | 1*10 Tablets |
| Manufacturer | DR REDDY'S LABORATORIES LTD |
| Usage/Application | Commercial |
| Salt Composition | Temozolomide Capsules |
| Brand Name | Glioz 250mg |
Glioz 250mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Glioz 250mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Glioz 250mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to be associated with Glioz 250mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Glioz 250mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low levels of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 100 mg |
| Brand | Glioz |
| Capsules per Pack | 5 Capsules |
| Manufacturer | DR REDDY'S LABORATORIES LTD |
| Usage/Application | Commercial |
| Brand Name | Glioz 100mg |
| Salt Composition | Temozolomide Capsules |
| Pack size | 1*5 Capsules |
Glioz 100mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antineoplastic agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Glioz 100mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Glioz 100mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Glioz 100mg Capsule are nausea, vomiting, dizziness, diarrhoea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Glioz 100mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 20 mg |
| Brand | Temotero |
| Capsules per Pack | 5 Capsules |
| Manufacturer | Hetero Healthcare Ltd |
| Usage/Application | Hospital |
| Salt Composition | Temozolomide 20mg Capsules |
| Country of Origin | India |
| Pack Size | 5 Capsule(s) In A Bottle |
Temotero 20mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temotero 20mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temotero 20mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Temotero 20mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temotero 20mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 20 mg |
| Brand | Temoside |
| Capsules per Pack | 5 Capsules |
| Pack Type | Bottle |
| Form | Capsule |
| Prescription Type | Prescription |
| Salt Composition | Temozolomide Capsules |
| Marketer | CIPLA LTD |
Temoside 20mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temoside 20mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temoside 20mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Temoside 20mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temoside 20mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Strength | 100 mg |
| Brand | Temotero |
| Capsules per Pack | 5 Capsules |
| Manufacturer | Hetero Healthcare Ltd |
| Usage/Application | Hospital |
| Pack Size | 5 Capsule(s) In A Bottle |
| Salt Composition | Temozolomide 100mg Capsules |
| Country of Origin | India |
Temotero 100mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temotero 100mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temotero 100mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Temotero 100mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temotero 100mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child. Temotero 100 mg price varies by location and retailer.
View Complete details
Product Brochure
| Strength | 100 mg |
| Brand | Temorel |
| Capsules per Pack | 5 Capsules |
| Pack Type | Bottle |
| Form | Capsule |
| Usage | Treatment of newly diagnosed glioblastoma multiforme. |
| Prescription Type | Prescription |
| Salt Composition | Temozolomide Capsules |
| Marketer | RELIANCE LIFE SCIENCES PVT LTD |
Tamorel 100mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Tamorel 100mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Tamorel 100mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Tamorel 100mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Tamorel 100mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
View Complete details
Product Brochure
| Treatment Type | chemotherapy |
| Dosage Form | Injection |
| Brand | Temozorix |
| Strength | 100 mg |
| Packaging Type | Vial |
| Manufacturer | THERDOSE PHARMA PVT LTD |
| Usage/Application | Hospital |
| Country of Origin | Made in India |
| Brand Name | Temozorix 100mg |
| Salt Composition | Temozolomide Injection |
Temozorix 100mg Injection contains temozolomide, an anti-cancer medicine used primarily to treat certain types of brain tumours, such as glioblastoma multiforme and anaplastic astrocytoma. These are aggressive forms of brain cancer that typically require intensive treatment. Temozorix works by damaging the DNA of cancer cells, stopping them from growing and multiplying.
Doctors may prescribe this injection if the tumour has returned or is not responding well to earlier treatments like surgery or radiotherapy. In many cases, Temozorix is used alongside radiation therapy during initial treatment and continued as part of maintenance therapy to keep the cancer from coming back.
View Complete details